AimMax Therapeutics, Inc. — Form D
AimMax Therapeutics, Inc. of CHAPEL HILL, NC, a company, filed a Form D exempt-offering notice with the SEC on 2017-04-17. The offering totals $200K, of which $200K was reported sold. Industry: Other.
Offering
- Filed: 2017-04-17
- Form: D
- Accession: 0001701803-17-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $200K
- Amount sold: $200K
- Investors: 1
- Date of first sale: 2017-04-14
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-284929
Issuer
- Name: AimMax Therapeutics, Inc.
- CIK: 0001701803
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 512 BOOTH ROAD, CHAPEL HILL, NC, 27516
- Phone: 919-968-4500
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Laurene Wang | Director | Chapel Hill, NC |
| Laurene Wang | Executive Officer | Chapel Hill, NC |
More